Countering Counterfeiters and Diverters – PharmTech

“The pharmaceutical industry has been on the leading edge of anticounterfeiting and brand protection efforts for many years. “Anticounterfeit solutions are usually tailor-made according to the needs of the brand owner,” says Paavo Sillanpää, senior business manager, Pharma at UPM Raflatac.”

Read More

Mediledger completes FDA blockchain pilot with 7 of top 10 pharma firms – Ledger Insights

California Designated Representative Training – for wholesalers or 3PL According to the article: “Blockchain startup Mediledger has published the results of its FDA blockchain pilot for the pharmaceutical supply chain. Numerous separate groups applied to the FDA and ran pilots for the Drug Supply Chain Security Act (DSCSA) 2023 milestone for package-level tracing, with this […]

Read More

Here comes drug importation – Pharmaceutical Commerce

3 distinct Board-approved California Designated Representative online training classes for wholesalers, 3PL, reverse distributors. Earns a training affidavit. According to the article: “The Trump Administration wants to start a drug-importation program from Canada for both small-molecule and biologic products. The program would be a “time-limited Section 804 importation program” (SIP), with the SIP program sponsored […]

Read More

FDA Enforcement Delay of Wholesale Distributor Verification Requirement for Saleable Returns – LSPediA

3 distinct Board-approved California Designated Representative training programs for: wholesalers; third-party logistics providers; reverse distributors. Earns a Board-recognized training affidavit. “The US FDA published a compliance policy final guidance document on September 23, 2019, announcing a one-year enforcement discretion for the Wholesale Distributor Verification Requirement for Saleable Returned Drug Product. If you’re a wholesaler or […]

Read More